tradingkey.logo

TriSalus Life Sciences Inc <TLSI.OQ> expected to post a loss of 22 cents a share - Earnings Preview

ReutersMay 13, 2025 2:34 PM
  • TriSalus Life Sciences Inc TLSI.OQ TLSI.O is expected to show a rise in quarterly revenue when it reports results on May 15 for the period ending March 31 2025

  • The Westminster Colorado-based company is expected to report a 39.9% increase in revenue to $9.036 million from $6.46 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for TriSalus Life Sciences Inc is for a loss of 22 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 2.0% in the last three months. ​

  • Wall Street's median 12-month price target for TriSalus Life Sciences Inc is $11.00​, above​ its last closing price of $5.11. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.34

-0.32

-0.40

Missed

-26

Sep. 30 2024

-0.35

-0.35

-0.12

Beat

65.3

Jun. 30 2024

-0.49

-0.49

-0.21

Beat

57.4​

Mar. 31 2024

-0.58

-0.65

-0.60

Beat

7.7

​​Dec. 31 2023

-0.69

-0.69

-1.56

Missed

-126.1

This summary was machine generated May 13 at 14:34 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI